News

Introducing AI/works™: Transforming Software Development

Introducing AI/works™: Transforming Software Development

AI/works™ Unveiled for Modern Software Development

Thoughtworks' agentic development platform developed to support both technology modernization and greenfield development.

Thoughtworks, a global technology consultancy known for integrating design, engineering, and AI to propel digital transformation, has introduced AI/works™. This innovative agentic development platform is designed to set a new benchmark for upgrading legacy systems and crafting next-generation technology solutions in the AI-driven landscape. With AI/works™, Thoughtworks aims to enhance the quality of technology developments while optimizing the overall economics involved in building, maintaining, and operating enterprise-class solutions.

Why AI/works™ Matters in Today’s Tech Environment

Over the years, Thoughtworks has significantly influenced the methodologies behind modern software delivery practices such as Agile, microservices, and continuous delivery. The launch of AI/works™ extends this legacy into the era defined by artificial intelligence and cognitive computing. By harmonizing the understanding of legacy systems, refining requirements, generating dynamic automated specifications, and enabling agentic code generation and testing into a singular platform, AI/works™ is tailored to meet the needs of complex organizational environments.

Bridging the Gap in AI Adoption

The adoption of AI is rapidly advancing across various sectors; however, many organizations still face hurdles caused by the disparity between their AI aspirations and the realities of their outdated systems. While several new agentic platforms presume a clean-slate architecture or limited productivity enhancements, AI/works™ is meticulously crafted for the hybrid environments that most enterprises navigate today.

Transforming Delivery Cycles

AI/works™ seamlessly integrates these disparate realms into a unified workflow. Initial clients adopting the platform have reported modernization projects that previously required years can now be completed within months. This transition not only leads to notable cost savings but also significantly enhances time-to-market, while simultaneously fostering the production of higher-quality code.

The platform embodies Thoughtworks' 3-3-3 delivery model, paving the way from conception to deployment within a notably efficient 90-day timeframe. It also aligns well with leading technological ecosystems, such as AWS, Google Cloud, Microsoft Azure, Databricks, and Snowflake. Additionally, through collaborative efforts with Mechanical Orchard, AI/works™ supports comprehensive mainframe renewal.

Insights from Thoughtworks Leadership

"Every CEO and CIO I meet is striving to extract AI's value from their existing infrastructures, rather than operating within idealized greenfield scenarios," commented Mike Sutcliff, CEO of Thoughtworks. "AI/works™ is explicitly engineered for these real-world conditions. It comprehends the systems organizations currently operate and accelerates the development of the solutions they will require, adapting to the ever-evolving tech landscape. The synergy between the platform's capabilities and our talented technologists results in swift and confident outcomes."

Continuous Improvement Through AI Innovation

AI/works™ leverages AI-driven reverse engineering to decode legacy applications and transform them into structured specifications, enriched with regulatory, security, and contextual industry insights. These specifications inform agentic workflows that create production-ready code, automated testing sequences, and deployment pipelines. After deployment, the platform persists in regenerating the impacted components as requirements evolve, thus minimizing dependency on frequent manual patches and avoiding extensive reconfigurations.

A Competitive Edge in Agentic Engineering

The realm of agentic engineering is swiftly evolving into a competitive domain. Although many prominent firms are entering this arena, most available tools target the acceleration of new coding endeavors, neglecting the more profound structural obstacles faced by large organizations.

"AI/works™ distinguishes itself as it comprehensively addresses the whole lifecycle—from grasping and renewing legacy systems to creating what’s next," stated R "Ray" Wang, CEO at Constellation Research. "This sets a new standard for the category."

Availability and Next Steps

AI/works™ is currently accessible through a co-innovation program, with plans for a broader rollout as part of Thoughtworks' ongoing AI initiatives in the upcoming quarters. Organizations interested in exploring this groundbreaking platform are invited to reach out for a demonstration.

Frequently Asked Questions

What is AI/works™?

AI/works™ is an advanced agentic development platform introduced by Thoughtworks to modernize legacy systems and develop new technology solutions.

How does AI/works™ improve software delivery?

The platform accelerates modernization cycles from years to months, resulting in significant cost savings and faster time-to-market.

What industries can benefit from AI/works™?

AI/works™ is designed for complex enterprise environments across various industries looking to enhance their legacy systems and integrate AI solutions.

Who developed AI/works™?

AI/works™ was developed by Thoughtworks, a leading global technology consultancy known for integrating design, engineering, and AI.

What strategic partnerships support AI/works™?

AI/works™ works alongside major cloud service providers like AWS, Google Cloud, and Microsoft Azure to enhance integration and functionality.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 9

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 8

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 19

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 19

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 12

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 17

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

America's Car-Mart Secures $300 Million Loan for Growth

Updated Category News Views 255

America's Car-Mart Secures Funding for Future Growth America's Car-Mart, Inc. (NASDAQ: CRMT), a leading automotive retailer, has taken a strategic step by closing a significant five-year, $300 million term loan. This loan, managed by the seasoned professionals at Silver Point Capital, L.P., aims to enhance the company’s capital structure and support its long-term growth...

Continue Reading
IASO Bio's Breakthrough Drug Application Acceptance in Singapore

Updated Category News Views 251

IASO Bio’s Major Step Forward with New Drug Application IASO Biotherapeutics, a pioneering biopharmaceutical company dedicated to the advancement of innovative cell therapies and biologics, has reached a significant milestone. The Singapore Health Sciences Authority (HSA) has officially accepted the New Drug Application (NDA) for Equecabtagene Autoleucel, known as...

Continue Reading
Creating Community Leaders: National Heritage Academies and United Way

Updated Category News Views 150

Empowering Students to Make a Difference The student-led organization is providing career opportunities while connecting with the community. National Heritage Academies® (NHA) is thrilled to celebrate its collaboration with United Way through the Student United Way program. This initiative equips high school students with essential tools and opportunities to enact...

Continue Reading
Future Growth of Augmented and Virtual Reality Technologies

Updated Category News Views 259

Exploring the Growth of Augmented Reality and Virtual Reality Market The global market for Augmented Reality (AR) and Virtual Reality (VR) is on the rise, with expectations of substantial growth over the next few years. Analysts estimate that this sector will expand by approximately USD 442.99 billion between 2024 and 2028. The compound annual growth rate (CAGR) for this...

Continue Reading
ImmVira Launches Innovative Exosome, Transforming Cosmetics

Updated Category News Views 407

ImmVira Leads the Way with Groundbreaking Exosome Technology In a remarkable advancement for the cosmetic industry, ImmVira Group has announced its innovative product, MVR-EX103, an engineered exosome specifically developed for treating superficial skin depressions. This development marks a pivotal moment, as it has successfully acquired the International Nomenclature...

Continue Reading